AlphAIalphai — Financial news for AI agents
fool.comAUG 203 min read$AVAH

Aveanna Healthcare (AVAH) Q2 2026 Earnings Call Transcript

Aveanna Healthcare (AVAH) reported Q2 2026 revenue of $670.5M, up 13.7% YoY, with adjusted EBITDA of $95.4M, up 8%. All segments grew, with Private Duty Services leading at $553.9M, up 14%. The company raised full-year revenue guidance to over $2.68B and adjusted EBITDA to over $365M. Management highlighted strategic payer alignments, acquisitions, and cost efficiencies.

Original reporting
fool.com
Published Aug 20, 2026, 3:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 3:08 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Aveanna Healthcare (AVAH) Q2 2026 Earnings Call Transcript — source image
Source · fool.com
Decision brief

The 30-second read

$AVAHBullishHigh
01

Why it matters

The earnings beat and guidance raise expectations for earnings per share and cash flow, likely supporting a bullish stance.

02

Market read

First disclosure of Q2 results and upgraded guidance provides fresh material for traders; likely to move AVAH stock.

03

What to watch

Potential headwinds from labor market tightening and future regulatory changes in Medicaid reimbursement.

Relevance 9/10Novelty 9/10Timing: Q2 2026 earnings release

Background

Aveanna Healthcare Holdings (AVAH) reported its Q2 2026 earnings, highlighting revenue growth across all segments and raising full‑year guidance.

Company-level read

Ticker impact

$AVAHBullishHigh confidence
Context

Q2 2026 earnings released with revenue $670.5M (+13.7% YoY) and raised full-year guidance above $2.68B.

Expected impact

Potential price appreciation on the back of better-than-expected results and higher guidance.

Evidence & confidence

Revenue beat expectations, margins expanding, and guidance raised, all new information for investors.

Market effects

Sector

Home health and hospice sector may see renewed investor interest as Aveanna raises growth outlook.

Regional

California rate increase could benefit other home‑health providers operating in the state.

Global

Limited; impact primarily on U.S. healthcare services sector.

Counterpoint

What could challenge this read

Higher guidance may already be priced in; watch for execution risk on integration of recent acquisitions.

Key entities

  • Executive
    Jeffrey Shaner

    CEO of Aveanna Healthcare, discussed growth outlook and upcoming California rate increase.

  • Executive
    Matthew Buckhalter

    CFO, noted interest expense reduction and debt hedging.

Read at source← All news

Related articles

AUG 13
$AVAHHighAI 9/10

Why is Aveanna Healthcare stock surging today?

Aveanna Healthcare (AVAH) shares rose about 10.5% in pre-open after the company raised its 2026 revenue outlook to more than $2.68B from prior guidance of $2.63B to $2.65B. Aveanna reported Q2 adjusted EPS of $0.22 vs $0.17 expected, and revenue of $670.5M vs $638.6M expected, citing early contribution from its Family First Homecare acquisition.

investing.com3 min
AUG 13
$AVAHHigh

Aveanna Healthcare Holdings, Inc. (AVAH): Results of Operations and Financial Condition

Aveanna Healthcare Holdings, Inc. (AVAH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 avah-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND QUARTER FINANCIAL RESULTS AND REVISED 2026 GUIDANCE • Second Quarter Revenue was $670.5 million, a 13.7% increase over the prior year period • Second Quarter Net income was $40.3 m

SEC EDGAR 8-K4 min
JUL 3
$AVAHMed

Bain, KKR, KV Asia shortlisted for Malaysia’s Avisena Healthcare stake sale as valuation hits US$368 million: sources

Bain Capital, KKR and KV Asia have been shortlisted to buy a 20–25% minority stake in Malaysia’s Avisena Healthcare, valuing the company at about RM1.5 billion (US$368m), according to two sources. Binding bids are due by end-July. The stake is estimated at RM300–400m. KKR and Bain declined comment; Avisena and KV Asia did not respond.

businesstimes.com.sg3 min
AUG 20
$LOWMed

Lowe’s Cuts Full-Year Sales Outlook as DIY Spending Remains Under Pressure

Lowe's (NYSE:LOW) reduced its full-year sales forecast due to weak DIY spending, with CEO Marvin Ellison citing a challenging environment. Q2 net sales rose 8.3% YoY to $25.96B, missing estimates. Adjusted EPS was $4.40, beating expectations. The company now expects flat comparable sales and narrowed its revenue forecast to $92B. Shares fell over 2% in premarket trading.

yahoo.com2 min